132. Targeting ferroptosis cell death for cancer and beyond, Luba Greenwood, CEO, Kojin Therapeutics

132. Targeting ferroptosis cell death for cancer and beyond, Luba Greenwood, CEO, Kojin Therapeutics

Synopsis: Luba Greenwood is the CEO of Kojin Therapeutics and Managing Partner of Dana Farber Cancer Institute Venture Fund. Kojin Therapeutics harnesses groundbreaking discoveries in cell state and ferroptosis biology to create novel therapies and cures for diseases traditionally considered intractable. The Dana Farber Cancer Institute Venture Fund accelerates the development of new research and technologies to treat incurable diseases, particularly in oncology and immunology. Luba discusses the early years of her career as a lawyer and how her legal experience relates to running a biotech company, her background in big pharma at Pfizer and Roche, and the work Kojin is doing in novel biology. She also dives into the qualities that she values in a board member, the importance of company culture, and her perspective on what good leadership looks like. Biography: Luba Greenwood is a leading figure in the biotech and digital health world with vast experience as an executive, investor, and company builder in the biotech, life sciences, diagnostics, and tech sectors. Luba is the Chief Executive Officer of Kojin Therapeutics, a world leader in ferroptosis, pioneering breakthrough medicines in oncology, immunology, neuro, metabolism, and inflammation. Most recently, Luba has served as the Managing Partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital, which she has built and launched. She has also taught at Harvard University at the School of Engineering and Applied Sciences. Previously, Ms. Greenwood served in leadership roles at Google Life Sciences, Verily, and was a VP Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub. Ms. Greenwood has led $5B+ in deals and investments across multiple therapeutic areas and life sciences globally. She has also co-founded companies in the oncology, AI/ML, women’s health and microbiome space. Luba began her career as a lawyer, practicing at Wilmer Cutler Pickering Hale and Dorr. She is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(263)

Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery

Nick Myerberg, Partner & Head of AI at Braidwell on AI's Next Era in Drug Discovery

Synopsis: The guest on today's podcast is a representative of Braidwell LP, a registered investment adviser. Braidwell invests on behalf of its clients and either holds, or may in the future hold, p...

3 Elo 47min

Robert Jacks, CEO of Sparrow Pharmaceuticals | Precision Medicine, Biotech Strategy & Leadership

Robert Jacks, CEO of Sparrow Pharmaceuticals | Precision Medicine, Biotech Strategy & Leadership

Synopsis: In an industry often defined by rapid innovation and high-stakes science, long-term success in biotech requires more than breakthrough discoveries—it demands strategic clarity, resilient l...

22 Heinä 34min

Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients

Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients

Synopsis: While biotech is increasingly measured by clinical milestones and financial outcomes, Rahul Chaturvedi welcomes two leaders who argue that true success begins and ends with patients. In th...

10 Kesä 41min

Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision

Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision

Synopsis: At the intersection of personal mission and biotech leadership, Rahul Chaturvedi sits down with Catherine Owen Adams, CEO of Acadia Pharmaceuticals, for a deeply personal and strategically...

13 Touko 33min

Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership

Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership

Synopsis: This episode is proudly sponsored by Quartzy. At a time when biotech innovation is being reshaped by science, capital, and global dynamics, Alok Tayi sits down with Barry Quart, CEO of Co...

16 Huhti 23min

Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics

Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics

Synopsis: Addiction is often misunderstood as a failure of willpower—but emerging science increasingly shows it may be deeply rooted in biology. In this episode of Biotech 2050, recorded during JPM...

6 Maalis 14min

Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders

Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders

Synopsis: This episode is proudly sponsored by Quartzy. Physician-scientist, biotech founder, and leadership advocate Sheila Gujrathi, MD joins Rahul Chaturvedi on the Biotech 2050 Podcast for a po...

5 Maalis 39min

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms

Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could ...

11 Helmi 25min

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
utelias-mieli
docemilia
rss-mita-tulisi-tietaa
rss-hereilla
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-ylistys-elaimille
rss-tiedetta-vai-tarinaa
hippokrateen-vastaanotolla
mielipaivakirja
rss-ammamafia
rss-astetta-parempi-elama-podcast
sotataidon-ytimessa
ihanat-ipanat
rss-bios-podcast
rss-kasvikutsut
rss-duodecim-lehti
rss-sotepodi-ratkaisuja-hyvinvointiin
filocast-filosofian-perusteet